In human serous ovarian cancer cells, SOX2 overexpression increased CSC marker expression, sphere formation, and in vivo tumorigenic activity, with little effect on cell proliferation [25]. This evidence concerns the gene SOX2 and ovarian serous adenocarcinoma.